Why GTM Strategies Need Fit-for-Purpose Data?

A successful Go-to-Market (#GTM) strategy starts with asking the right questions — and having the right data to answer them.

#NSCLC offers a clear example: when teams leverage mutation-specific insights (like EGFR and ALK), they unlock sharper targeting, tailored messaging, and more meaningful HCP engagement.

Fit-for-purpose data transforms GTM strategies — making them faster, more focused, and far more effective.

1. Why GTM Strategies
Need Fit-for-Purpose
Data?
NSCLC as a Use
Case in Oncology
Commercialization

2. Inefficient targeting
Missed market opportunities
Suboptimal resource
allocation>
>
>
Most pharma GTM strategies
rely on generic data
THE
PROBLEM

THE RESULT?

3. NSCLC Example
Hyper-targeted outreach
by mutation clusters
THE
FIX
IN NSCLC, MUTATION-SPECIFIC
RWD (E.G., EGFR, ALK) ENABLES:
>
Engaging the right oncologists
with tailored messaging
>
Smarter education via
webinars on precision
treatments>

4.
GTM strategies powered by
fit-for-purpose data are faster,
sharper, and more effective
FINAL
INSIGHT
It’s not just about data—
it’s about the right data